1. 1604 Influence of academic and regulatory environment on the management of cancer associated thrombosis (CAT) in France: A survey among vascular disease and supportive care specialists. (September 2015) Authors: Scotté, F.; Mayeur, D.; Rey, J.B.; Elalamy, I.; Lamblin, A.; Pernod, G.; Mahé, I. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ADAMTS‐13 and von Willebrand factor predict venous thromboembolism in patients with cancer. (25th January 2016) Authors: Pépin, M.; Kleinjan, A.; Hajage, D.; Büller, H. R.; Di Nisio, M.; Kamphuisen, P. W.; Salomon, L.; Veyradier, A.; Stepanian, A.; Mahé, I. Journal: Journal of thrombosis and haemostasis Issue: Volume 14:Number 2(2016:Feb.) Page Start: 306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Factors influencing adherence to clinical guidelines in the management of cancer‐associated thrombosis. (20th October 2016) Authors: Mahé, I.; Chidiac, J.; Helfer, H.; Noble, S. Journal: Journal of thrombosis and haemostasis Issue: Volume 14:Number 11(2016:Nov.) Page Start: 2107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long‐term treatment of cancer‐associated thrombosis: the choice of the optimal anticoagulant. (21st March 2017) Authors: Elalamy, I.; Mahé, I.; Ageno, W.; Meyer, G. Journal: Journal of thrombosis and haemostasis Issue: Volume 15:Number 5(2017) Page Start: 848 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC-17 Rivaroxaban vesus Dalteparin for the Treatment of Cancer- Associated Venous Thromboembolism: the CASTA DIVA Trial. Issue 200 (April 2021) Authors: Meyer, G.; Girard, P.; Bertoletti, L.; Nelson, A.C.; Laporte, S.; Mahé, I.; Sanchez, O.; Mismetti, P. Journal: Thrombosis research Issue: Issue 200(2021)Supplement 1 Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO-0753: Radiation therapy and outcome in cancer patients with acute venous thromboembolism. (May 2017) Authors: Guy, J.B.; Bertoletti, L.; Magné, N.; Mahé, I.; Font, C.; Sanz, O.; Martín-Antorán, J.M.; Pace, F.; Ramón Vela, J.; Monreal, M. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PO-23 - Expression of heparanase in cancer as biomarker of malignancies: overexpression in an aggressive, poor survival gastric cancer "gastric signet ring cell carcinoma" compared with that of other gastric cancers. Issue 140 (April 2016) Authors: Fourgeaud, C.; Derieux, S.; Mirshahi, S.; Besbes, S.; Chidiac, J.; Mahé, I.; Contant, G.; Pocard, M.; Soria, J.; Mirshahi, M. Journal: Thrombosis research Issue: Issue 140(2016)Supplement 1 Page Start: S184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PO-33: Real-world VTE and implemented treatments in patients with cancer: an observational study in the French EGB database. Issue 213 (May 2022) Authors: Mahé, I.; Mayeur, D.; Chouaid, C.; Gaudry, J.L.; Foist, M.; Pertus, D.; Spiess, N. Journal: Thrombosis research Issue: Issue 213(2022)Supplement 2 Page Start: S25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PO-41: Cancer-associated thrombosis: how many patients seen in clinical practice would be eligible to a randomized controlled trial?. Issue 213 (May 2022) Authors: Petit, B.; Soudet, S.; Poenou, G.; Zarrat, E.; Machuron, T.; Accassat, S.; Plaisance, L.; Helfer, H.; Mismetti, V.; Le Hello, C.; Sevestre, M.-A.; Mahé, I.; Bertoletti, L. Journal: Thrombosis research Issue: Issue 213(2022)Supplement 2 Page Start: S30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PO-47 - Microparticles derived from ovarian cancer cell line contained genomic and biologically active proteins, including tissue factor involved in coagulation. Issue 140 (April 2016) Authors: Besbes, S.; Attal, R.; Mirshahi, S.; Chidiac, J.; Mahé, I.; Pocard, M.; Soria, J.; Mirshahi, M. Journal: Thrombosis research Issue: Issue 140(2016)Supplement 1 Page Start: S194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗